Skip to content

Opening book details…

Can I read Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors on EtoBox?

Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors by Rajesh Subramaniam; Manas K. Haldar; Shakila Tobwala; Bratati Ganguly; D.K. Srivastava; Sanku Mallik is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors about?

A series of bis-(arylsulfonamide) hydroxamate inhibitors were synthesized. These compounds exhibit good potency against MMP-7 and MMP-9 depending on the nature, steric bulk, and substitution pattern of the substituents in the benzene ring. In general, the preliminary structure-activity relationships (SAR) suggest that among the DAPA hydroxamates (i) electron-rich benzene rings of the sulfonamides may produce better inhibitors than electron-poor analogs. However, potential H-bond acceptors can reverse the trend depending on the isozyme; (ii) isozyme selectivity between MMP-7 and -9 can be conferred through steric bulk and substitution pattern of the substituents in the benzene ring, and (iii) the MMP-10 inhibition pattern of the compounds paralleled that for MMP-9.

Who reads Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Rajesh Subramaniam; Manas K. Haldar; Shakila Tobwala; Bratati Ganguly; D.K. Srivastava; Sanku Mallik
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0960-894X)
Published
2008
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)